294 related articles for article (PubMed ID: 33950476)
1. A Systematic Review of Discrete Choice Experiments in Oncology Treatments.
Collacott H; Soekhai V; Thomas C; Brooks A; Brookes E; Lo R; Mulnick S; Heidenreich S
Patient; 2021 Nov; 14(6):775-790. PubMed ID: 33950476
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease.
Collacott H; Zhang D; Heidenreich S; Tervonen T
Patient; 2022 Jan; 15(1):55-68. PubMed ID: 34250574
[TBL] [Abstract][Full Text] [Related]
4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
5. Risk as an attribute in discrete choice experiments: a systematic review of the literature.
Harrison M; Rigby D; Vass C; Flynn T; Louviere J; Payne K
Patient; 2014; 7(2):151-70. PubMed ID: 24566923
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Attribute Development in Health-related Discrete Choice Experiments: A Systematic Review of Qualitative Methods and Techniques to Inform Quantitative Instruments.
Bohorquez NG; Malatzky C; McPhail SM; Mitchell R; Ai Lim MH; Kularatna S
Value Health; 2024 Jun; ():. PubMed ID: 38851483
[TBL] [Abstract][Full Text] [Related]
8. Discrete choice experiments in health economics: a review of the literature.
Clark MD; Determann D; Petrou S; Moro D; de Bekker-Grob EW
Pharmacoeconomics; 2014 Sep; 32(9):883-902. PubMed ID: 25005924
[TBL] [Abstract][Full Text] [Related]
9. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
10. Comparing Discrete Choice Experiment with Swing Weighting to Estimate Attribute Relative Importance: A Case Study in Lung Cancer Patient Preferences.
Veldwijk J; Smith IP; Oliveri S; Petrocchi S; Smith MY; Lanzoni L; Janssens R; Huys I; de Wit GA; Groothuis-Oudshoorn CGM
Med Decis Making; 2024 Feb; 44(2):203-216. PubMed ID: 38178591
[TBL] [Abstract][Full Text] [Related]
11. What attributes should be included in a discrete choice experiment related to health technologies? A systematic literature review.
Trapero-Bertran M; Rodríguez-Martín B; López-Bastida J
PLoS One; 2019; 14(7):e0219905. PubMed ID: 31318926
[TBL] [Abstract][Full Text] [Related]
12. Patients' Preferences for Outcome, Process and Cost Attributes in Cancer Treatment: A Systematic Review of Discrete Choice Experiments.
Bien DR; Danner M; Vennedey V; Civello D; Evers SM; Hiligsmann M
Patient; 2017 Oct; 10(5):553-565. PubMed ID: 28364387
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Discrete Choice Experiments and Conjoint Analysis on Genetic Testing.
Ozdemir S; Lee JJ; Chaudhry I; Ocampo RRQ
Patient; 2022 Jan; 15(1):39-54. PubMed ID: 34085205
[TBL] [Abstract][Full Text] [Related]
14. Differences in Preferences for Drug Therapy Between Patients with Metastatic Versus Early-Stage Breast Cancer: A Systematic Literature Review.
Brandstetter LS; Jírů-Hillmann S; Störk S; Heuschmann PU; Wöckel A; Reese JP
Patient; 2024 Jul; 17(4):349-362. PubMed ID: 38451419
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of Patients' Values, Preferences, and Expectations for the Treatment of Metastatic Prostate Cancer.
Connor MJ; Genie MG; Burns D; Bass EJ; Gonzalez M; Sarwar N; Falconer A; Mangar S; Dudderidge T; Khoo V; Winkler M; Ahmed HU; Watson V
Eur Urol Open Sci; 2022 Feb; 36():9-18. PubMed ID: 34977691
[TBL] [Abstract][Full Text] [Related]
16. Patient preferences for the treatment of type 2 diabetes: a scoping review.
Joy SM; Little E; Maruthur NM; Purnell TS; Bridges JF
Pharmacoeconomics; 2013 Oct; 31(10):877-92. PubMed ID: 24081453
[TBL] [Abstract][Full Text] [Related]
17. Attributes in stated preference elicitation studies on colorectal cancer screening and their relative importance for decision-making among screenees: a systematic review.
Brinkmann M; Fricke LM; Diedrich L; Robra BP; Krauth C; Dreier M
Health Econ Rev; 2022 Sep; 12(1):49. PubMed ID: 36136248
[TBL] [Abstract][Full Text] [Related]
18. Stakeholders' preferences for the design and delivery of virtual care services: A systematic review of discrete choice experiments.
Vo LK; Allen MJ; Cunich M; Thillainadesan J; McPhail SM; Sharma P; Wallis S; McGowan K; Carter HE
Soc Sci Med; 2024 Jan; 340():116459. PubMed ID: 38048738
[TBL] [Abstract][Full Text] [Related]
19. Patient Preferences in Targeted Pharmacotherapy for Cancers: A Systematic Review of Discrete Choice Experiments.
Jiang S; Ren R; Gu Y; Jeet V; Liu P; Li S
Pharmacoeconomics; 2023 Jan; 41(1):43-57. PubMed ID: 36372823
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]